These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34278981)

  • 1. Cannabis use prior to legalisation among alcohol consumers in the Canadian Yukon and Northwest territories.
    Hammond D; Goodman S; Hobin E
    Int J Circumpolar Health; 2021 Dec; 80(1):1948254. PubMed ID: 34278981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse outcomes of cannabis use in Canada, before and after legalisation of non-medical cannabis: cross-sectional analysis of the International Cannabis Policy Study.
    Marquette A; Iraniparast M; Hammond D
    BMJ Open; 2024 Jan; 14(1):e077908. PubMed ID: 38171626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of cannabis use and the frequency, types, and sources of cannabis products used in northern remote territories of the Canadian legal cannabis market.
    Hobin E; Schwartz N; Poon T; Hammond D
    Can J Public Health; 2024 May; ():. PubMed ID: 38760617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How has access to legal cannabis changed over time? An analysis of the cannabis retail market in Canada 2 years following the legalisation of recreational cannabis.
    Myran DT; Staykov E; Cantor N; Taljaard M; Quach BI; Hawken S; Tanuseputro P
    Drug Alcohol Rev; 2022 Feb; 41(2):377-385. PubMed ID: 34250645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Home cultivation across Canadian provinces after cannabis legalization.
    Wadsworth E; Cristiano N; Pacheco K; Jesseman R; Hammond D
    Addict Behav Rep; 2022 Jun; 15():100423. PubMed ID: 35434251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and forms of cannabis use in legal vs. illegal recreational cannabis markets.
    Goodman S; Wadsworth E; Leos-Toro C; Hammond D;
    Int J Drug Policy; 2020 Feb; 76():102658. PubMed ID: 31927413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Legal sourcing of ten cannabis products in the Canadian cannabis market, 2019-2021: a repeat cross-sectional study.
    Wadsworth E; Rynard V; Driezen P; Freeman TP; Rychert M; Wilkins C; Hall W; Gabrys R; Hammond D
    Harm Reduct J; 2023 Feb; 20(1):19. PubMed ID: 36803833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testing the Effectiveness of Enhanced Alcohol Warning Labels and Modifications Resulting From Alcohol Industry Interference in Yukon, Canada: Protocol for a Quasi-Experimental Study.
    Vallance K; Stockwell T; Hammond D; Shokar S; Schoueri-Mychasiw N; Greenfield T; McGavock J; Zhao J; Weerasinghe A; Hobin E
    JMIR Res Protoc; 2020 Jan; 9(1):e16320. PubMed ID: 31922493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of trends in the prevalence of cannabis use and related metrics in Canada.
    Rotermann M
    Health Rep; 2019 Jun; 30(6):3-13. PubMed ID: 31216047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of youth injury: a comparison across the northern territories and other parts of Canada.
    Byrnes J; King N; Hawe P; Peters P; Pickett W; Davison C
    Int J Circumpolar Health; 2015; 74():27864. PubMed ID: 26300557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baseline Assessment of Alcohol-Related Knowledge of and Support for Alcohol Warning Labels Among Alcohol Consumers in Northern Canada and Associations With Key Sociodemographic Characteristics.
    Vallance K; Stockwell T; Zhao J; Shokar S; Schoueri-Mychasiw N; Hammond D; Greenfield TK; McGavock J; Weerasinghe A; Hobin E
    J Stud Alcohol Drugs; 2020 Mar; 81(2):238-248. PubMed ID: 32359055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of problematic cannabis use in Canada pre- and post-legalisation: Differences by neighbourhood deprivation, individual socioeconomic factors and race/ethnicity.
    Fataar F; Driezen P; Owusu-Bempah A; Hammond D
    Drug Alcohol Rev; 2023 Sep; 42(6):1534-1546. PubMed ID: 37137866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carnitine palmitoyltransferase 1A (CPT1A) P479L prevalence in live newborns in Yukon, Northwest Territories, and Nunavut.
    Collins SA; Sinclair G; McIntosh S; Bamforth F; Thompson R; Sobol I; Osborne G; Corriveau A; Santos M; Hanley B; Greenberg CR; Vallance H; Arbour L
    Mol Genet Metab; 2010; 101(2-3):200-4. PubMed ID: 20696606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The health of northern residents.
    Diverty B; Pérez C
    Health Rep; 1998; 9(4):49-58(Eng); 51-61(Fre). PubMed ID: 9836880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient transportation in Canada's northern territories: patterns, costs and providers' perspectives.
    Young TK; Tabish T; Young SK; Healey G
    Rural Remote Health; 2019 May; 19(2):5113. PubMed ID: 31128577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-reported Impact of the COVID-19 Pandemic on Cannabis Use in Canada and the United States.
    Wadsworth E; Goodman S; Hammond D
    J Psychoactive Drugs; 2023; 55(4):483-492. PubMed ID: 35981105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in the use of cannabis products in Canada and the USA, 2018 - 2020: Findings from the International Cannabis Policy Study.
    Hammond D; Goodman S; Wadsworth E; Freeman TP; Kilmer B; Schauer G; Pacula RL; Hall W
    Int J Drug Policy; 2022 Jul; 105():103716. PubMed ID: 35613480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disparities in modifiable cancer risk factors among Canadian provinces, territories, and health regions.
    Abdel-Rahman O
    Curr Med Res Opin; 2021 Nov; 37(11):1973-1989. PubMed ID: 34414833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between noticing public health education campaigns about cannabis and risk perceptions in the northern Canadian territories: a cross-sectional study.
    Schwartz N; Poon T; Hammond D; Hobin E
    Health Educ Res; 2024 Jun; ():. PubMed ID: 38905013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabis and mental health: Prevalence of use and modes of cannabis administration by mental health status.
    Rup J; Freeman TP; Perlman C; Hammond D
    Addict Behav; 2021 Oct; 121():106991. PubMed ID: 34087766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.